Note 9 - Stock Incentive Plans

The Company's 2020 Stock Incentive Plan (the "2020 Plan"), which provides for share-based awards to Company employees, non-employee directors and outside consultants or advisors, was approved by stockholders on May 27, 2020, and amended with stockholder approval on June 5, 2023, to increase the number of shares available for issuance under the 2020 Plan from 1,500,000 to 2,900,000. The number of shares available for grants of awards at December 31, 2025 was 592,654.

Share-based compensation expense included in selling, general and administrative expenses during the years ended December 31, 2025, 2024 and 2023, was $10.4 million, $8.8 million and $8.5 million, respectively. Related income tax benefits for the years ended December 31, 2025, 2024 and 2023, were $2.6 million, $2.2 million and $1.6 million, respectively.

Stock Options

Outstanding stock options generally vest over four or eight years and expire up to ten years after the date of grant.

A summary of the status of the Company’s stock options at December 31, 2025, together with changes during the periods then ended, is presented below:

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Intrinsic

 

 

 

Number

 

 

Exercise

 

 

Contractual

 

 

Value

 

 

 

of Options

 

 

Price

 

 

Term (Years)

 

 

(In Thousands)

 

Outstanding at December 31, 2024

 

 

414,000

 

 

$

20.60

 

 

 

 

 

 

 

Options exercised

 

 

(131,500

)

 

 

15.74

 

 

 

 

 

 

 

Outstanding at December 31, 2025

 

 

282,500

 

 

 

22.87

 

 

 

2.50

 

 

 

4,030

 

Exercisable at December 31, 2025

 

 

88,000

 

 

$

18.88

 

 

 

2.03

 

 

$

1,525

 

 

 

The fair value of stock option awards as determined under the Black-Scholes option-pricing model was estimated with the following weighted-average assumptions:

 

 

 

2024

 

Expected volatility

 

 

24.4

%

Risk free interest rate

 

 

4.2

%

Expected dividend yield

 

 

0.7

%

Expected term (years)

 

 

5.0

 

Weighted average fair value per share

 

$

12.16

 

 

No stock options were granted during the years ended December 31, 2025 or 2023. The weighted average fair value of stock options granted for the year ended December 31, 2024 was $12.16. There were no stock options granted with an exercise price below market price during 2024.

 

The intrinsic value of stock options exercised for the years ended December 31, 2025, 2024 and 2023 was $4.0 million, $0.6 million, and $0.1 million, respectively. The fair value of stock options vested for the years ended December 31, 2024 was $728,000. No stock options vested during the years ended December 31, 2025 or 2023. As of December 31, 2025, unrecognized compensation expense related to stock options was $0.5 million with a weighted average remaining amortization period of 1.9 years.

Restricted Stock Units

Restricted stock units generally vest in four equal annual installments beginning one year following the date of grant, other than restricted stock units granted to nonemployee directors, which vest one year following the date of grant.

The following table presents restricted stock unit activity:

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

Grant Date

 

 

 

Units

 

 

Fair Value

 

Nonvested at December 31, 2024

 

 

760,857

 

 

$

24.10

 

Granted

 

 

213,033

 

 

 

42.02

 

Vested

 

 

(294,173

)

 

 

22.35

 

Cancelled/Forfeited

 

 

(46,737

)

 

 

24.95

 

Nonvested at December 31, 2025

 

 

632,980

 

 

$

30.88

 

 

The total fair value of restricted stock units vested during the years ended December 31, 2025, 2024 and 2023 was $6.6 million, $6.3 million and $5.1 million, respectively. As of December 31, 2025, unrecognized compensation expense related to restricted stock units was $14.9 million with a weighted average remaining amortization period of 2.7 years.

Performance Share Units

Performance share units (“PSUs”) are granted to key employees of the Company and are conditioned on attaining financial performance metrics specified in each award. Each award is subject to upward or downward adjustment depending on whether achievement of the financial metrics is above or below the target level, with a maximum payout of up to 200% of the target number of shares covered by the award.

PSUs vest on the date that the Compensation Committee determines the level of attainment of the specified financial metrics, generally measured over a three-year period.

The following table presents PSU activity:

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

Grant Date

 

 

 

Units

 

 

Fair Value

 

Nonvested at December 31, 2024

 

 

265,748

 

 

$

22.01

 

Granted

 

 

103,576

 

 

 

34.32

 

Vested

 

 

(118,020

)

 

 

15.04

 

Nonvested at December 31, 2025

 

 

251,304

 

 

$

30.36

 

 

The total grant date fair value of PSUs vested during the years ended December 31, 2025, 2024 and 2023 was $1.8 million, $1.7 million, and $1.6 million, respectively.

Employee Stock Purchase Plan

The Company offers employees the right to purchase shares at a discount from the market price under the Company’s 2019 Employee Stock Purchase Plan. Subject to the annual statutory limit, employees are eligible to participate through payroll deductions of up to 15% of their compensation. At the end of each six-month offering period, shares are purchased by the participants at 85% of the fair market value at the end of the offering period. As of December 31, 2025, approximately 993,278 shares were reserved for future issuance under the 2019 Employee Stock Purchase Plan.

Historical Timeline

Fiscal YearFiled
2025Feb 26, 2026Showing above
2018Mar 5, 2019
2017Mar 6, 2018
2016Mar 8, 2017

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.